Bioequivalence Study of Valsartan 320mg Tablets Under Fasting Conditions
NCT02197442
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Valsartan
Sponsor
Ranbaxy Laboratories Limited